4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-21-026782
Director sold 12,045 shares at an average $106.34 ($1,280,897)
- Director acquired 12,045 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| COOPER GRAHAM K Director | 2021-06-28 | Option exercise | +12,045 | $17.00 | $204,765 | 12,045 | D |
| COOPER GRAHAM K Director | 2021-06-28 | Sale | −5,787 | $105.37 | $609,776 | 6,258 | D |
| COOPER GRAHAM K Director | 2021-06-28 | Sale | −3,196 | $106.28 | $339,671 | 3,062 | D |
| COOPER GRAHAM K Director | 2021-06-28 | Sale | −1,162 | $107.22 | $124,590 | 1,900 | D |
| COOPER GRAHAM K Director | 2021-06-28 | Sale | −900 | $108.30 | $97,470 | 1,000 | D |
| COOPER GRAHAM K Director | 2021-06-28 | Sale | −1,000 | $109.39 | $109,390 | 0 | D |
| Derivatives | |||||||
| COOPER GRAHAM K Director | 2021-06-28 | Option exercise · Stock Option (Right to Buy) | −12,045 | 19,175 | D | ||
| Open-market sales · 12,045 sh · avg $106.34 · $1,280,897 | |||||||
Loading xslF345X03/doc4.xml…